Three-year safety check for immune disease treatment continues
NCT ID NCT05513586
Summary
This study followed 15 Japanese patients with primary immunodeficiency diseases for 3 years to check long-term side effects of TAK-771 injections. Participants had already completed a previous study and received regular injections during clinic visits. The main goal was to monitor safety and track any side effects that developed over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY IMMUNODEFICIENCY DISEASES (PID) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gifu University Hospital
Gifu, Gifu, Japan
-
Hiroshima University Hospital
Hiroshima, Hiroshima, Japan
-
Hospital of University of Occupational and Environmental Health
Kitakyushu, Fukuoka, Japan
-
Kanagawa Children's Medical Center
Yokohama, Kanagawa, Japan
-
Kyushu University Hospital
Fukuoka, Fukuoka, Japan
-
Nagoya University Hospital
Nagoya, Aichi-ken, Japan
-
Saitama Prefectual Children's Medical Center
Saitama, Saitama, Japan
-
Shizuoka Childrens Hospital
Shizuoka, Shizuoka, Japan
-
Tokyo Medical Dental University Hospital
Bunkyo-ku, Tokyo, Japan
Conditions
Explore the condition pages connected to this study.